Dow Jones U.S. Pharmaceuticals Index
D.J. US Pharmaceutical Top 10: Value Investment Strategy
TOP 10 Value
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Phibro Animal (L, US) Pharmaceuticals
1. Phibro Animal (L, US) Pharmaceuticals
78
1
43
23
2. Pfizer (XXL, US) Pharmaceuticals
2. Pfizer (XXL, US) Pharmaceuticals
62
10
33
19
3. Lannett (M, US) Pharmaceuticals
3. Lannett (M, US) Pharmaceuticals
58
1
42
27
4. Assertio Therapeutics (S, US) Pharmaceuticals
4. Assertio Therapeutics (S, US) Pharmaceuticals
57
1
1
10
5. Merck & Co. (XXL, US) Pharmaceuticals
5. Merck & Co. (XXL, US) Pharmaceuticals
53
40
40
31
6. Supernus Pharma (M, US) Pharmaceuticals
6. Supernus Pharma (M, US) Pharmaceuticals
52
50
61
62
January 29, 2021. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Growth Investment Strategy
TOP 10 Growth
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Zoetis (XL, US) Pharmaceuticals
1. Zoetis (XL, US) Pharmaceuticals
20
100
27
50
2. Catalent (L, US) Pharmaceuticals
2. Catalent (L, US) Pharmaceuticals
18
100
15
42
3. Pacira BioSciences (M, US) Pharmaceuticals
3. Pacira BioSciences (M, US) Pharmaceuticals
20
92
46
58
4. Prestige (L, US) Pharmaceuticals
4. Prestige (L, US) Pharmaceuticals
40
82
24
41
5. Nektar (L, US) Pharmaceuticals
5. Nektar (L, US) Pharmaceuticals
11
81
31
25
6. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
6. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
24
81
10
21
7. Eli Lilly (XXL, US) Pharmaceuticals
7. Eli Lilly (XXL, US) Pharmaceuticals
11
74
40
24
8. AbbVie (XXL, US) Biotechnology
8. AbbVie (XXL, US) Biotechnology
38
71
5
21
9. Heska (S, US) Pharmaceuticals
9. Heska (S, US) Pharmaceuticals
4
68
42
40
10. Supernus Pharma (M, US) Pharmaceuticals
10. Supernus Pharma (M, US) Pharmaceuticals
52
50
61
62
January 29, 2021. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Safety Investment Strategy
TOP 10 Safety
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Amphastar (M, US) Pharmaceuticals
1. Amphastar (M, US) Pharmaceuticals
24
25
69
25
2. Supernus Pharma (M, US) Pharmaceuticals
2. Supernus Pharma (M, US) Pharmaceuticals
52
50
61
62
3. Pacira BioSciences (M, US) Pharmaceuticals
3. Pacira BioSciences (M, US) Pharmaceuticals
20
92
46
58
4. Phibro Animal (L, US) Pharmaceuticals
4. Phibro Animal (L, US) Pharmaceuticals
78
1
43
23
5. Heska (S, US) Pharmaceuticals
5. Heska (S, US) Pharmaceuticals
4
68
42
40
January 29, 2021. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Combined Investment Strategy
TOP 10 Combined
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Supernus Pharma (M, US) Pharmaceuticals
1. Supernus Pharma (M, US) Pharmaceuticals
52
50
61
62
2. Pacira BioSciences (M, US) Pharmaceuticals
2. Pacira BioSciences (M, US) Pharmaceuticals
20
92
46
58
3. Zoetis (XL, US) Pharmaceuticals
3. Zoetis (XL, US) Pharmaceuticals
20
100
27
50
4. Catalent (L, US) Pharmaceuticals
4. Catalent (L, US) Pharmaceuticals
18
100
15
42
5. Prestige (L, US) Pharmaceuticals
5. Prestige (L, US) Pharmaceuticals
40
82
24
41
January 29, 2021. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
☀ This company has a special achievement which is documented on its stock research page.
Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards .
Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value , Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from January 29, 2021.
Top 10 Stock History D.J. US Pharmaceutical
Select Top 10 Date
Apr‑2021
Jan‑2021
Aug‑2020
Mar‑2020
Oct‑2019
Apr‑2019
Nov‑2018
Jun‑2018
Oct‑2017
Apr‑2017
Jan‑2017
Jan‑2016
Jan‑2015
Jan‑2014